Molecular Neurobiology

, Volume 53, Issue 1, pp 310–319 | Cite as

AlzBase: an Integrative Database for Gene Dysregulation in Alzheimer’s Disease

  • Zhouxian Bai
  • Guangchun Han
  • Bin Xie
  • Jiajia Wang
  • Fuhai Song
  • Xing Peng
  • Hongxing Lei


Alzheimer’s disease (AD) affects a significant portion of elderly people worldwide. Although the amyloid-β (Aβ) cascade hypothesis has been the prevailing theory for the molecular mechanism of AD in the past few decades, treatment strategies targeting the Aβ cascade have not demonstrated effectiveness as yet. Thus, elucidating the spatial and temporal evolution of the molecular pathways in AD remains to be a daunting task. To facilitate novel discoveries in this filed, here, we have integrated information from multiple sources for the better understanding of gene functions in AD pathogenesis. Several categories of information have been collected, including (1) gene dysregulation in AD and closely related processes/diseases such as aging and neurological disorders, (2) correlation of gene dysregulation with AD severity, (3) a wealth of annotations on the functional and regulatory information, and (4) network connections for gene-gene relationship. In addition, we have also provided a comprehensive summary for the top ranked genes in AlzBase. By evaluating the information curated in AlzBase, researchers can prioritize genes from their own research and generate novel hypothesis regarding the molecular mechanism of AD. To demonstrate the utility of AlzBase, we examined the genes from the genetic studies of AD. It revealed links between the upstream genetic variations and downstream endo-phenotype and suggested several genes with higher priority. This integrative database is freely available on the web at


Brain transcriptome Genetics Aging Neurological disorders Network 



This work was supported by the grants from the National Basic Research Program of China (973 Program, Grant No. 2014CB964901) and National High Technology Research and Development Program (863 Program, Grant No. 2015AA020100) awarded to HL from the Ministry of Science and Technology of China.

Conflict of Interest

The authors declare that there are no conflicts of interest.

Supplementary material

12035_2014_9011_MOESM1_ESM.docx (21 kb)
Supplementary Table 1 (DOCX 21 kb)
12035_2014_9011_MOESM2_ESM.docx (19 kb)
Supplementary Table 2 (DOCX 18 kb)
12035_2014_9011_MOESM3_ESM.docx (18 kb)
Supplementary Table 3 (DOCX 17 kb)
12035_2014_9011_MOESM4_ESM.docx (17 kb)
Supplementary Table 4 (DOCX 16 kb)
12035_2014_9011_MOESM5_ESM.docx (150 kb)
Supplementary Figure 1 (DOCX 150 kb)
12035_2014_9011_MOESM6_ESM.docx (528 kb)
Supplementary Figure 2 (DOCX 528 kb)
12035_2014_9011_MOESM7_ESM.docx (370 kb)
Supplementary Figure 3 (DOCX 370 kb)


  1. 1.
    Lei H (2010) Amyloid and Alzheimer’s disease. Protein Cell 1(4):312–314CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Han G et al (2014) Genomics in neurological disorders. Genomics Proteomics Bioinformatics 12(4):156–163CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Herrup K et al (2013) Beyond amyloid: getting real about nonamyloid targets in Alzheimer’s disease. Alzheimers Dement 9(4):452–458 e1CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bertram L et al (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1):17–23CrossRefPubMedGoogle Scholar
  5. 5.
    Lambert JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Zhang B et al (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell 153(3):707–720CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sun J et al (2012) Down-regulation of energy metabolism in Alzheimer’s disease is a protective response of neurons to the microenvironment. J Alzheimers Dis 28(2):389–402PubMedGoogle Scholar
  8. 8.
    Liang D et al (2012) Concerted perturbation observed in a hub network in Alzheimer’s disease. PLoS One 7(7):e40498CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wang J et al (2014) Chromosome 19p in Alzheimer’s disease: when genome meets transcriptome. J Alzheimers Dis 38:245–250PubMedGoogle Scholar
  10. 10.
    Hahs DW et al (2006) A genome-wide linkage analysis of dementia in the Amish. Am J Med Genet B Neuropsychiatr Genet 141B(2):160–166CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wijsman EM et al (2004) Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75(3):398–409CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Feng X et al (2014) Robust gene dysregulation in Alzheimer’s disease brains. J Alzheimers Dis 41:587–597PubMedGoogle Scholar
  13. 13.
    Han G et al (2013) Characteristic transformation of blood transcriptome in Alzheimer’s disease. J Alzheimers Dis 35:373–386PubMedGoogle Scholar
  14. 14.
    Bai Z et al (2014) Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities. Alzheimer Dis Assoc Disord 28(3):226–233CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Sun J et al (2014) Hidden risk genes with high-order intragenic epistasis in Alzheimer’s disease. J Alzheimers Dis 41:1039–1056PubMedGoogle Scholar
  16. 16.
    Hawrylycz MJ et al (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489(7416):391–399CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Welter D et al (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42(Database issue):D1001–D1006CrossRefPubMedGoogle Scholar
  18. 18.
    Webster JA et al (2009) Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84(4):445–458CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Berchtold NC et al (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 105(40):15605–15610CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Liang WS et al (2008) Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 105(11):4441–4446CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Nunez-Iglesias J et al (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer’s disease cortex reveals altered miRNA regulation. PLoS One 5(2):e8898CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Williams C et al (2009) Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS One 4(3):e4936CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Iwamoto K et al (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9(4):406–416CrossRefPubMedGoogle Scholar
  24. 24.
    Iwamoto K, Bundo M, Kato T (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14(2):241–253CrossRefPubMedGoogle Scholar
  25. 25.
    Hodges A et al (2006) Regional and cellular gene expression changes in human Huntington’s disease brain. Hum Mol Genet 15(6):965–977CrossRefPubMedGoogle Scholar
  26. 26.
    Moran LB et al (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease. Neurogenetics 7(1):1–11CrossRefPubMedGoogle Scholar
  27. 27.
    Ryan MM et al (2006) Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11(10):965–978CrossRefPubMedGoogle Scholar
  28. 28.
    Lesnick TG et al (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 3(6):e98CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Harris LW et al (2008) The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS One 3(12):e3964CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Maycox PR et al (2009) Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 14(12):1083–1094CrossRefPubMedGoogle Scholar
  31. 31.
    Zheng B et al (2010) PGC-1alpha, a potential therapeutic target for early intervention in Parkinson’s disease. Sci Transl Med 2(52):52ra73CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Voineagu I et al (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474(7351):380–384CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ginsberg MR et al (2012) Brain transcriptional and epigenetic associations with autism. PLoS One 7(9):e44736CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Lu T et al (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429(6994):883–891CrossRefPubMedGoogle Scholar
  35. 35.
    Gibbs JR et al (2010) Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 6(5):e1000952CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Somel M et al (2010) MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res 20(9):1207–1218CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Colantuoni C et al (2011) Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478(7370):519–523CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Hernandez DG et al (2012) Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiol Dis 47(1):20–28CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Trabzuni D, Thomson PC (2014) Analysis of gene expression data using a linear mixed model/finite mixture model approach: application to regional differences in the human brain. Bioinformatics 30(11):1555CrossRefPubMedGoogle Scholar
  40. 40.
    Scherzer CR et al (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104(3):955–960CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Blalock EM et al (2004) Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101(7):2173–2178CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Dunckley T et al (2006) Gene expression correlates of neurofibrillary tangles in Alzheimer’s disease. Neurobiol Aging 27(10):1359–1371CrossRefPubMedGoogle Scholar
  43. 43.
    Kaizer EC et al (2007) Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 92(9):3705–3711CrossRefPubMedGoogle Scholar
  44. 44.
    Misu H et al (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 12(5):483–495CrossRefPubMedGoogle Scholar
  45. 45.
    Jin W et al (2011) Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest 121(3):918–929CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Keller P et al (2011) Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 11:7CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Skov V et al (2012) Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes. Cardiovasc Diabetol 11:15CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    van Tienen FH et al (2012) Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J Clin Endocrinol Metab 97(9):3261–3269CrossRefPubMedGoogle Scholar
  49. 49.
    Davis AP et al (2013) The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res 41(Database issue):D1104–D1114CrossRefPubMedGoogle Scholar
  50. 50.
    Irizarry RA et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249–264CrossRefPubMedGoogle Scholar
  51. 51.
    Hong F et al (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22(22):2825–2827CrossRefPubMedGoogle Scholar
  52. 52.
    Sun J et al (2012) iBIG: an integrative network tool for supporting human disease mechanism studies. Genomics Proteomics Bioinformatics 11(3):166–171CrossRefGoogle Scholar
  53. 53.
    Benjamini Y et al (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125(1–2):279–284CrossRefPubMedGoogle Scholar
  54. 54.
    Wickham H (2007) Reshaping data with the reshape package. J Stat Softw 21(12):1–20CrossRefGoogle Scholar
  55. 55.
    Ginestet C (2011) ggplot2: elegant graphics for data analysis. J Royal Stat Soc Series a-Stat Soc 174:245–245CrossRefGoogle Scholar
  56. 56.
    Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 9:559CrossRefGoogle Scholar
  57. 57.
    Csardi G, Nepusz T (2006) The igraph software package for complex network research. Inter J Compl Syst. 1695(5)Google Scholar
  58. 58.
    Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48CrossRefGoogle Scholar
  59. 59.
    Li W (1990) Mutual information functions versus correlation functions. J Stat Phys 60(516):823–836CrossRefGoogle Scholar
  60. 60.
    Jean Hausser KS (2009) Entropy inference and the James-Stein estimator, with application to nonlinear gene association networks. J Machine Learn Res. doi:10.1145/1577069.1755833Google Scholar
  61. 61.
    Wang J, Yu JT, Tan L (2014) PLD3 in Alzheimer’s disease. Mol Neurobiol. doi: 10.1007/s12035-014-8779-5 Google Scholar
  62. 62.
    Cruchaga C et al (2013) Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease. Nature 505(7484):550–554CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Akhtar MW et al (2012) In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS One 7(4):e34863CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Bienvenu T et al (2013) Refining the phenotype associated with MEF2C point mutations. Neurogenetics 14(1):71–75CrossRefPubMedGoogle Scholar
  65. 65.
    Ryan SD et al (2013) Isogenic human iPSC Parkinson’s model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155(6):1351–1364CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Wang X et al (2014) Genetic determinants of disease progression in Alzheimer’s disease. J Alzheimers Dis. doi: 10.3233/JAD-140729 PubMedCentralGoogle Scholar
  67. 67.
    Beecham GW et al (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer’s disease and related dementias. PLoS Genet 10(9):e1004606CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Zhouxian Bai
    • 1
    • 2
  • Guangchun Han
    • 1
  • Bin Xie
    • 1
  • Jiajia Wang
    • 1
    • 2
  • Fuhai Song
    • 1
    • 2
  • Xing Peng
    • 1
    • 2
  • Hongxing Lei
    • 1
    • 3
  1. 1.CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of GenomicsChinese Academy of SciencesBeijingChina
  2. 2.University of Chinese Academy of SciencesBeijingChina
  3. 3.Center of Alzheimer’s DiseaseBeijing Institute for Brain DisordersBeijingChina

Personalised recommendations